LAKENasdaqOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends January 31

LAKELAND INDUSTRIES INC

Financials through Q2 FY2027, quarter ended Jul 31, 2026Last filing: 10-Q on Sep 9, 2026

$9.38+0.29 (+3.19%)

Close on Oct 19, 2026

Market cap: $93.25M
P/E (TTM): –
Dividend yield: –

LAKELAND INDUSTRIES INC income statement

Annual Quarterly TTM

Millions of USD, except per-share data. Shares in millions.

Line item	FY 2026 2026-01-31	FY 2025 2025-01-31	FY 2024 2024-01-31	FY 2023 2023-01-31	FY 2022 2022-01-31	FY 2021 2021-01-31	FY 2020 2020-01-31	FY 2019 2019-01-31	FY 2018 2018-01-31	FY 2017 2017-01-31	FY 2016 2016-01-31	FY 2015 2015-01-31	FY 2014 2014-01-31	FY 2013 2013-01-31	FY 2012 2012-01-31	FY 2011 2011-01-31
Revenue	193	167	125	113	118	159	108	99	96	86	100	93	91	95	96	100
Cost of Revenue	129	99	73	67	67	80	70	65	60	55	63	62	67	68	68	69
Gross Profit	63	69	51	46	51	79	38	34	36	32	36	32	25	27	29	30
Research & Development	–	–	–	–	–	0.20	0.20	0.20	0.28	0.46	0.17	0.09	0.12	0.24	0.43	–
General & Administrative	–	–	–	–	–	–	–	–	–	–	–	15	13	15	15	14
Advertising Expenses	1.20	0.90	0.60	0.50	0.50	0.70	1.00	0.80	0.44	0.34	0.33	0.46	0.32	0.26	0.31	–
Operating Expenses	77	67	45	40	35	35	32	30	28	25	25	25	25	28	27	26
Operating Income	-16	-9.27	5.99	5.54	16	44	5.88	3.57	8.48	6.85	12	6.96	-0.36	-1.03	1.74	4.12
Interest Expense	2.15	1.65	0.05	0.04	0.02	0.02	0.12	0.13	0.16	0.62	0.79	1.69	2.19	0.91	0.68	0.34
Other Non-Operating Income	-0.04	0.20	3.42	–	0.12	0.05	-0.01	0.04	0.03	0.05	-0.12	-2.38	0.05	–	-0.60	-1.83
Asset Impairment Charges	3.60	-11	0	–	–	–	–	–	0	0	0	–	0	0.80	0	–
Gain (Loss) on Sale of Assets	-0.11	-0.06	3.76	0.01	-0.04	0.01	0.02	-0.02	0.00	-0.14	-0.02	-0.04	0	–	–	–
Pretax Income	-18	-18	9.36	5.47	16	44	5.75	3.48	8.34	6.27	11	2.90	-2.97	-21	0.84	2.29
Income Tax Expense	7.61	-0.28	3.93	3.60	4.78	8.58	2.47	2.02	7.90	2.38	3.12	-8.19	-2.85	5.04	-0.25	0.89
Income from Continuing Operations	–	–	–	–	–	–	–	–	0.44	3.89	7.79	11	-0.12	-26	1.09	1.40
Income from Discontinued Operations	–	–	–	–	–	–	–	–	0	0	-3.94	-2.69	0	-0.52	-1.47	-0.42
Net Income incl. Noncontrolling Interests	-25	-18	5.43	1.87	11	35	3.28	–	–	–	–	–	–	–	–	–
Net Income	-25	-18	5.43	1.87	11	35	3.28	1.46	0.44	3.89	3.85	8.40	-0.12	-26	-0.38	0.97
EPS (Basic)(per share)	-2.63	-2.43	0.74	0.25	1.44	4.43	0.41	0.18	0.06	0.54	0.54	1.35	-0.02	-4.97	-0.07	0.18
EPS (Diluted)(per share)	-2.63	-2.43	0.72	0.24	1.41	4.34	0.41	0.18	0.06	0.53	0.53	1.33	-0.02	-4.97	-0.07	0.18
Shares Outstanding (Basic, Weighted)(shares)	9.63	7.43	7.35	7.56	7.90	7.98	8.01	8.11	7.64	7.26	7.17	6.21	5.69	5.29	5.22	5.44
Shares Outstanding (Diluted, Weighted)(shares)	9.63	7.43	7.54	7.74	8.05	8.14	8.04	8.17	7.69	7.33	7.25	6.33	5.69	5.29	5.36	5.52
EBITDA	-13	-6.67	7.89	7.05	18	46	7.88	4.53	9.25	8.04	13	8.07	1.25	0.52	3.68	6.09
Provision for Credit Losses	–	–	–	–	–	–	–	–	0	0	2.29	0	–	–	–	–

Italic numbers are calculated by StockData (for example Q4 = full year − nine months). Per-share data and share counts are adjusted for stock splits. Hover a number for its source; click it to open the filing on SEC.gov. Click a row to chart it.

Ratios

Latest available, balances at Jul 31, 2026

Profitability, TTM

Gross margin: 32.6%
Operating margin: -4.1%
Net margin: -14.0%
Return on equity, FY2026: -18.4%

Financial strength

Current ratio: 2.98
Debt to equity: –
Debt to assets: –
Cash to current liabilities: 39.0%

Valuation

P/E ratio: –
Price to sales: 0.49
Price to book: 0.75
Dividend yield: –